- Exchange: -
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Genovis AB
GENOBTA1:SS
Ticker Delisted
Snapshot for Genovis AB (GENOBTA1)
| Open: | - | Day's Range: | - | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | - | 52wk Range: | - | 1-Yr Rtn: | - |
Key Statistics for GENOBTA1
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. OMX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M SEK) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/29/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GENOBTA1
Company Profile & Key Executives for GENOBTA1
Genovis AB develops transfection technologies based on nanotechnology. The Company develops new technologies to be used for research and developments within biotechnology, as well as for medical applications and by the food industry.
| Ebba Asly FahraeusChairman | Sarah FredrikssonChief Executive Officer |
| Fredrik OlssonChief Operating Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
GENOBTA1 News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page